News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
203 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39122)
2019 (51337)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (33090)
2026 (897)
Month
January (897)
Day
1 (17)
2 (20)
5 (162)
6 (203)
7 (146)
8 (247)
9 (102)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
Day
1
2
5
6
7
8
9
Obesity
Lilly Doubles Down With Nimbus, Paying $55M for Preclinical Obesity Drug
Eli Lilly kicked off a pivotal 2026 campaign with a multi-year collaboration with current partner Nimbus Therapeutics worth a potential $1.3 billion for a preclinical obesity therapeutic. The deal follows a 2022 partnership struck by the companies to target the AMPK protein in cardiometabolic diseases.
January 6, 2026
·
2 min read
·
Heather McKenzie
Neuroscience
Deep Dive: Huntington’s at a Crossroads
Recent breakthroughs and three decades of progress in treating Huntington’s disease
January 6, 2026
·
2 min read
·
Heather McKenzie
IPO
IPOs Slow to a Trickle in 2025 as Investors Grow More Discerning
After a strong open to the year, the public markets suffered a six-month drought that led to biotech’s tightest IPO window in years.
January 6, 2026
·
10 min read
·
Tristan Manalac
Press Releases
Idorsia’s daridorexant in women during menopausal transition age with insomnia
January 6, 2026
·
12 min read
Press Releases
GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy
January 6, 2026
·
3 min read
Press Releases
Alnylam to Webcast Presentation at 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026
·
2 min read
Press Releases
Orca Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026
·
1 min read
Press Releases
Amsino Announces Agreement with ampiezza, a Vizient Aggregation Group, for Pre-Filled Flush Syringes
January 6, 2026
·
2 min read
Press Releases
Karlyn Dauplaise of Vizient Joins Next Gen Diagnostics as Chief Commercial Officer
January 6, 2026
·
2 min read
Press Releases
Bayer to Present Updates on Pharma Growth Strategy and Pipeline Advancements at J.P. Morgan’s 44th Annual Healthcare Conference
January 6, 2026
·
2 min read
Previous
2 of 21
Next